14,474 results found

The European Medicines Agency ("EMA") has published a video and presentations from its June 24, 2015, webinar, which provide an update on the implementation of its Transparency Policy.

On July 28, 2015, EMA published a draft guideline on the processing of renewals in the centralized procedure.

During its July 2015 meeting, the European Medicines Agency ("EMA") Committee for Medicinal Products for Human Use ("CHMP") recommended for marketing authorization 10 new medicines.

On November 17, 2014, Commission Regulation (EU) No 1228/2014 of 17 November 2014 authorising and refusing to authorise certain health claims made on foods and referring to the reduction of disease risk was issued.

On January 6, 2015, certain health claims relating to glucose were rejected by Commission Regulation (EU) 2015/8 of 6 January 2015...

On June 25, 2015, EC published two regulations, Regulation 2015/1005 and Regulation 2015/1006, which amend Regulation Annex No. 1881/2006 by setting maximum levels of lead and inorganic arsenic in certain foodstuffs, respectively.

On May 5, 2015, the EU published summaries of marketing authorizations granted during February and March 2015.

In 2012, the company faced similar issues with European regulators after refusing to allow inspectors into its facilities.

EFSA invites the public to observe the proceedings of the 64th Management Board meeting.

On January 26, 2015, the European Medicines Agency launched an electronic repository for periodic safety update reports ("PSURs") and their assessment reports.

On March 12, 2015, the European Commission issued Commission Regulation (EU) 2015/414 of 12 March 2015, amending Directive 2002/46/EC of the European Parliament and of the Council...

On March 31, 2015, the European Commission issued Commission Regulation (EU) 2015/539 authorizing the following health claim...

On March 31, 2015, the European Commission issued Commission Regulation (EU) 2015/545 authorizing the placing on the market of oil from the micro-algae Schizochytrium sp...

The aim of the new working arrangement is to strengthen communication between the respective organizations and make it easier to take action to protect public health.

On April 7, 2017, the Commission Implementing Regulation 2017/660 ("Regulation") was published in the Official Journal of the EU.

On March 19, 2015, the European Commission issued new guidelines on risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use.

On March 30, 2015, the European Commission published the new version of Annex 15 "Qualification and Validation" of EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use.

The monitoring data should be supplied to EFSA.